Log In
BCIQ
Print this Print this
 

ARC-2022

  Manage Alerts
Collapse Summary General Information
Company Arcion Therapeutics Inc.
DescriptionTopical formulation of lidocaine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard IndicationNeuralgia
Indication DetailsTreat post-herpetic neuralgia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today